Markel Corporation Form 10-Q Summary
Filing and period: Markel Corporation (the registrant named in this 2020 filing; not “Markel Group Inc.”), quarter ended March 31, 2020. Amounts below are U.S. dollars. Results are unaudited.
Business context and reporting period
Markel is a diversified financial holding company focused on specialty insurance and reinsurance, with additional Markel Ventures businesses, investing activities, insurance-linked securities and program services operations. The quarter was materially affected by COVID-19-related equity-market declines and estimated insurance losses.
Financial results and position
| Metric | Q1 2020 | Q1 2019 / comparison |
|---|---|---|
| Earned premiums | $1.331 billion | $1.204 billion; up 11% |
| Total operating revenues | $335.7 million | $2.472 billion |
| Net investment gains (losses) | $(1.681) billion | $612.2 million |
| Operating income (loss) | $(1.805) billion | $794.8 million |
| Net income (loss) to shareholders | $(1.406) billion; $(100.60) per share | $576.4 million; $42.81 per share |
| Net cash from operating activities | $65.7 million | $18.7 million |
| Invested assets, including cash and restricted cash | $20.5 billion | $22.3 billion at Dec. 31, 2019 |
| Senior long-term and other debt | $3.594 billion | $3.534 billion at Dec. 31, 2019 |
| Shareholders’ equity / book value per share | $9.721 billion / $705.68 | $11.071 billion / $802.59 at Dec. 31, 2019 |
The negative revenue and earnings comparison primarily reflects the $1.7 billion decline in the fair value of equity securities, recognized in earnings under the company’s accounting policy. Net investment income fell to $88.2 million from $114.2 million. The taxable-equivalent total investment return was negative 7.0%, versus positive 5.4% a year earlier.
Underwriting produced a $240.8 million loss versus $61.0 million profit; the consolidated GAAP combined ratio rose to 118% from 95%. Insurance and Reinsurance combined ratios were 119% and 115%, respectively. Markel Ventures operating revenue increased to $511.2 million from $455.0 million and operating income to $41.8 million from $29.9 million.
Cash, cash equivalents and restricted cash totaled $4.458 billion at quarter-end. Cash from investing activities was $906.6 million, including a $942.7 million net reduction in short-term investments. The debt-to-capital ratio was 27%, compared with 24% at year-end. The filing reports sufficient liquidity, but does not provide a specific earnings or full-year financial forecast.
Material changes versus the prior comparable period
- Equity-market losses reversed the prior-year investment gains and drove the company to a substantial quarterly net loss.
- COVID-19 contributed $325 million of estimated net incurred losses, including $293 million in Insurance and $32 million in Reinsurance.
- Premium growth continued: underwriting gross premium volume rose 13%, and net written premiums increased to $1.646 billion from $1.477 billion. Insurance growth was partly offset by flat Reinsurance volume.
- Prior-year reserve development was favorable by $104.1 million, versus $70.2 million favorable in Q1 2019; this partly offset current-year losses.
- Shareholders’ equity fell by about $1.35 billion from year-end. Markel suspended share repurchases in March after repurchasing $23.9 million during the quarter.
Outlook, commentary, risks and unusual items
- COVID-19 reserves and exposure: Management described the $325 million estimate as its best estimate based on information then available, while emphasizing that few claims had been reported and no comparable historical event informed the estimate. Coverage interpretation, reinsurance recoveries, litigation, legislation and the duration of disruption could materially change ultimate losses.
- Business and liquidity outlook: Management warned that reduced economic activity could reduce premium volume, prompt premium refunds, delay collections and affect Markel Ventures revenue, working capital and liquidity. Certain Ventures businesses had cancellations, postponed orders or reduced capacity. The company was increasing cash holdings, pausing equity purchases and suspending buybacks; it said liquidity remained adequate.
- Capital and investments: The fixed-maturity portfolio averaged “AA,” with 98% rated A or better. Equity securities were 28% of invested assets at quarter-end, down from 34% at year-end. Further market declines, credit losses or reduced dividend income could affect results and capital.
- Impairment: Markel did not consider impairment testing necessary for its $4.0 billion of goodwill and intangible assets at March 31, but said further deterioration or weaker-than-expected performance could lead to material impairment charges.
- Acquisitions and commitments: Markel agreed to acquire a controlling interest in Lansing Building Products alongside Lansing’s acquisition of Harvey’s distribution business, for estimated combined consideration of $546.7 million, expected in cash and subject to closing conditions. The company also committed, subject to conditions, to invest up to $100 million in Lodgepine Fund Limited.
- Legal and regulatory matters: Government inquiries into Markel CATCo reserves remained ongoing. A former executive’s arbitration was scheduled for August 2020; Markel said it considered the claims without merit. The filing also describes a separate contingent-value-rights dispute and potential product-remediation costs, with $20.2 million accrued at quarter-end.
- Other developments: Markel CATCo and related funds were in run-off, expected to take approximately three years. Effective April 1, 2020, Markel combined its Markel Assurance and Markel Specialty divisions. The filing reports no material change in disclosure controls.
Important facts for investors to verify
- How COVID-19 claim emergence, coverage litigation and any regulatory or legislative action compare with the assumptions underlying the $325 million net loss estimate.
- Subsequent equity-portfolio performance, investment concentration and the effect of market movements on book value, capital and debt-to-capital.
- Renewals, premium trends, retention and combined ratios in Insurance and Reinsurance, including whether further pandemic-related losses emerge.
- Cash generation, premium collections, reinsurance recoverables and credit allowances as economic conditions affect policyholders, customers and reinsurers.
- Closing, funding and performance of the Lansing/Harvey transactions, and any material updates on Markel CATCo inquiries, arbitration and other contingencies.